| |
|
|
|
CASI Pharmaceuticals Inc.  
|
|
3.11 -0.23 (-0.07%) |
03-22 16:00 |
|
Open: |
3.31 |
Pre close: |
3.34 |
Target:
|
4.15
|
|
High: |
3.31 |
Low: |
3.11 |
Resistance:
|
3.55
3.83
|
|
Volume: |
207,185 |
Market Cap: |
296M |
Support:
|
3.10
2.58
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.28
 |
MACD |
MACD(12,26):
|
-0.07 |
|
MA(20): |
3.30 |
Signal(12,26,9): |
-0.08  |
|
MA(100): |
3.68 |
Stochastic Oscillator |
%K(14,3):
|
48.96 |
|
MA(250): |
5.29 |
%D(3): |
56.75 |
|
Average Volume(K) |
3-Month: |
26079
|
52-Week |
High:
|
8.89 |
|
10-Days: |
16075 |
Low: |
2.73 |
|
RSI |
RSI(14):
|
36.28 |
Change(%): |
-22.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.300 |
Return on Equity (ttm) |
-36.1 |
Shares Out. (M) |
93.59 |
|
EPS Est. Current Year |
-0.150 |
Return on Assets (ttm) |
-32.5 |
Shares Float (M) |
91.69 |
|
EPS Est. Next Year |
-0.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.20 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
17.80 |
|
Forward EPS |
-0.190 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
2.670 |
EBITDA (p.s.) |
0.000 |
P/E |
-10.37 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.16 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-14.23 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-26.74 |
P/CF |
-20.45 |
|
|
|
|
|
|
